Hualan Bio Competitors and Similar CompaniesClear all

Hualan Bio's competitors and similar companies include Sun Pharma, Torrent Pharmaceuticals, Hikma Pharmaceuticals and Divis Laboratories.

	Hualan Bio Hualan Biological Engineering (华兰生物工程股份有限公司) is a company engaging in the research, development, production, and commercialization of medical products.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
Founding Date	Founding Date 1992	Founding Date 1983	Founding Date 1971	Founding Date 1978	Founding Date 1990
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare pharma	Tags Healthcare drug development pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Xinxiang, CN HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US
Employees	Employees 4,012	Employees 43,000	Employees 15,718	Employees 9,500	Employees 7,9267% increase
Valuation ($)	Valuation ($) 4.2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 5.6 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥4.5b (FY, 2025)	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) ₹105.6b (FY, 2026)
Cost of goods	Cost of goods ¥2b (FY, 2025)	Cost of goods ₹115.4b (FY, 2026)	Cost of goods ₹33.9b (FY, 2026)	Cost of goods $1.7b (FY, 2025)	Cost of goods ₹40.9b (FY, 2026)
Gross profit	Gross profit ¥2.6b (FY, 2025)	Gross profit ₹488.9b (FY, 2026)	Gross profit ₹105b (FY, 2026)	Gross profit $1.7b (FY, 2025)	Gross profit ₹69.7b (FY, 2026)
Net income	Net income ¥1b (FY, 2025)	Net income ₹115.6b (FY, 2026)	Net income ₹21.4b (FY, 2026)	Net income $407m (FY, 2025)	Net income ₹25.7b (FY, 2026)